factor XIII, human 1 UNT Injection [Corifact]
- RxCUI
- 1095283
- RxNorm name
- factor XIII, human 1 UNT Injection [Corifact]
- Display name
- factor XIII, human 1 UNT Injection [Corifact]
- Full name
- factor XIII, human 1 UNT Injection [Corifact]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:09
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125385 | Corifact | Factor XIII Concentrate (Human) | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 96f1b658-01b0-43a7-9aba-693271389a78 | Corifact 1 UNT Injection [PSN] · factor XIII, human 1 UNT Injection [Corifact] [SBD] · Corifact 1 UNT Injection [SY] | 3 | 14 | These highlights do not include all the information needed to use CORIFACT safely and effectively. See full prescribing information for CORIFACT. CORIFACT ® , Factor XIII Concentrate (Human) Lyophilized powder for solution for injection For intravenous use only. Initial U.S. Approval: 2011 | 20200818 |